MCRPC
Clinical trials for MCRPC explained in plain language.
Never miss a new study
Get alerted when new MCRPC trials appear
Sign up with your email to follow new studies for MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for men with aggressive prostate cancer
Disease control Recruiting nowThis is the first study in people testing a new drug called KTX2001 for advanced prostate cancer that has spread and stopped responding to standard hormone treatments. Researchers will give the drug alone and combined with an existing medication (darolutamide) to about 144 men to…
Matched conditions: MCRPC
Phase: PHASE1 • Sponsor: K36 Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Targeted radiation zaps advanced prostate cancer in new trial
Disease control Recruiting nowThis study is testing a new radioactive drug called lutetium (177Lu) rhPSMA-10.1 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies. The goal is to find a safe and effective dose that can shrink tumors by delivering rad…
Matched conditions: MCRPC
Phase: PHASE1, PHASE2 • Sponsor: Blue Earth Therapeutics Ltd • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC